NALCN and non-small cell lung carcinoma: Promoter methylation of NALCN was observed in 2 (5.1%) of 39 patients with early NSCLC, 4 (10.2%) of 39 patients with advanced NSCLC, and none (0%) of 10 healthy individuals (Figure 5).